Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$2.83 - $3.03 $30,564 - $32,723
-10,800 Reduced 29.67%
25,600 $75,000
Q4 2022

Feb 14, 2023

SELL
$2.39 - $3.07 $25,334 - $32,542
-10,600 Reduced 22.55%
36,400 $106,000
Q3 2022

Nov 14, 2022

SELL
$2.24 - $2.85 $33,600 - $42,750
-15,000 Reduced 24.19%
47,000 $113,000
Q2 2022

Aug 15, 2022

SELL
$1.99 - $2.33 $32,039 - $37,513
-16,100 Reduced 20.61%
62,000 $140,000
Q4 2021

Feb 14, 2022

SELL
$2.4 - $3.19 $133,200 - $177,045
-55,500 Reduced 41.54%
78,100 $195,000
Q3 2021

Nov 15, 2021

BUY
$2.28 - $16.9 $304,608 - $2.26 Million
133,600 New
133,600 $424,000

Others Institutions Holding PMCB

About PharmaCyte Biotech, Inc.


  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $35.3M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.